RAHWAY, N.J., April 14, 2025 -- The Merck Manuals is pleased to announce its collaboration with Microsoft to integrate its esteemed professional medical reference into healthcare agent service in Microsoft Copilot Studio. This exciting initiative harnesses the power of Generative AI (GenAI) to provide clinicians with trusted, comprehensive, and evidence-based medical content at the point of care.
The Merck Manuals is proud to be an independent (non-government) medical information resource integrated into this platform. This collaboration exemplifies a commitment to enhancing clinical workflows by incorporating Merck Manuals' authoritative content into Microsoft's healthcare agent service in Copilot Studio. This integration empowers healthcare technology developers to create generative AI-driven healthcare agents that leverage this high-value content to grant clinicians immediate access to vital medical information.
"Clinicians and healthcare organizations worldwide depend on the Merck Manuals and MSD Manuals for accurate and reliable answers to their clinical questions," stated Dr. Sandy Falk, Editor-in-Chief of the Merck Manuals. "Through this collaboration with Microsoft, we are building solutions to deliver our comprehensive, evidence-based content to meet the needs of healthcare professionals. By providing seamless access to trusted medical information, we are supporting clinicians in providing the best patient care."
For over 125 years, Merck Manuals has been a vital resource for clinical decision support worldwide, available in 15 languages. The content is written and peer-reviewed by leading academic medical experts and is provided without subscription fees or advertisements across websites, mobile apps, and EHR integrations, ensuring that healthcare professionals have access to accurate, unbiased, trusted medical information.
Healthcare agent service in Microsoft Copilot Studio allows healthcare organizations to develop generative AI-powered agents, while leveraging reusable healthcare-specific features, pre-built intelligence sourced from reputable medical references and clinical, chat and compliance safeguards. This collaboration will focus on both Microsoft's third-party and first-party applications, including Microsoft Dragon Copilot, where clinicians will be able to use GenAI to seamlessly surface credible medical information within voice-enabled and ambient clinical documentation workflows.
The Merck Manuals is known as the MSD Manuals outside of the US and Canada, and will be known as MSD Manuals in this platform.
Hadas Bitran, General Manager of Health AI at Microsoft Health & Life Sciences, said, "Our collaboration with the Merck Manuals and MSD Manuals aims to expand the potential of healthcare agent service in Microsoft Copilot Studio. By leveraging the rich, high-quality content from MSD Manuals, this platform further enables high-value use cases for our customers, and enhances the capabilities of our healthcare solutions."
Merck Manuals and Microsoft are both committed to responsible generative AI development and guiding efforts to ensure that technology operates in the best interests of healthcare providers and patients alike.
About the Merck Manuals
Merck Manuals (known as MSD Manuals outside the US and Canada) is a comprehensive medical resource, with contributions from more than 350 medical experts. Its content is reviewed by an independent editorial board and is regularly updated to maintain relevance and accuracy. Visitors to www.MerckManuals.com will find a continually expanding collection of assets, including news feeds, expert commentary, infographics, videos, podcasts, 3D models, as well as health calculators and trackers. Provided as a public service by Merck & Co., Inc., the digital offering represents the most current information derived from The Merck Manuals, a series of medical reference books that have long been trusted by healthcare professionals and patients.
About Merck
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology.
